For most of the last decade, IP-backed lending in the UK was theoretical for cleantech businesses. Pilots existed but they were concentrated in pharma, media and consumer-brand sectors with mature licensing markets. UK clearing banks did not have the framework — or the comfort — to advance against cleantech IP. Founders raising debt against a patent portfolio got polite refusals.
That has changed materially since 2024. The major UK clearing banks now have active IP-backed lending pilots that explicitly include cleantech as a priority sector. UKIPO and Treasury joint work has produced reference frameworks for cleantech IP collateralisation. Independent valuation firms have built cleantech-specific practice areas. Advance rates have moved from theoretical to standardised.
The result is that UK cleantech founders can now bring an IP register to a debt-financing conversation and expect a substantive response. The conversation is no longer about whether IP can be collateral — it is about what evidence supports the advance rate, what structure the facility takes, and what the founder needs to bring to make the deal bankable.
UK IP-backed lending for cleantech is no longer a pilot — it is an active product line at major clearing banks with standardised advance rates and structural frameworks. Founders who bring an IFRS-3-aligned IP register and externally valued fair-value evidence can move debt sizing materially on their own terms.
Three lender categories are active in UK cleantech IP-backed lending in 2026.
NatWest, HSBC and Lloyds run IP-backed lending pilots that explicitly accept cleantech IP. Advance rates are typically 50-65% of externally valued amount, with PPAs and grid rights at the upper end and unpatented know-how at the lower end. Facility sizes range from £2m to £50m. Terms are 3-5 years. The bank requires independent IP valuation alongside the credit pack.
A small group of specialist lenders (Aon IP Solutions UK, Inngot finance partnerships) offers IP-backed lending with broader risk tolerance than the clearing banks. Advance rates can exceed clearing bank levels but cost of debt is materially higher. Useful for cleantech businesses with strong IP but lacking the EBITDA profile that clearing banks require.
British Business Bank schemes — Growth Guarantee Scheme, Recovery Loan Scheme — now include IP-backed lending as eligible structures. Government guarantees reduce lender risk and produce more accommodating terms for SME cleantech borrowers. UKIPO and Innovate UK programmes provide pre-lending IP valuation grants.
| Lender category | Advance rate | Facility size | Cost of debt | Terms |
|---|---|---|---|---|
| UK clearing banks | 50-65% | £2-50m | Base + 3-6% | 3-5 yr |
| Specialist IP lenders | 50-75% | £1-20m | Base + 6-10% | 2-4 yr |
| Government-backed | 55-70% | £0.5-10m | Base + 4-7% | 3-6 yr |
Five elements move a cleantech IP-backed lending conversation from polite refusal to substantive engagement.
Lenders cannot evaluate a portfolio of 50 patents at a per-patent level. The register must group patents into technology families with claim breadth, remaining life, geographic coverage and enforcement status documented per family.
Opagio Intangibles produces this register through its Asset Valuator module — book a demo.
Each family needs an independent IFRS-3-aligned fair value. The valuation must include the method selected (RFR, MPEEM, W&W, cost), comparable evidence relied on, useful life, discount rate, and resulting fair value. Lenders cannot back-fill this work — it must exist before the credit pack is built.
Comparable evidence is the single most scrutinised element. Disclosed licence agreements, royalty databases (ktMINE, RoyaltyStat) and litigation-derived rates are strongest. Industry survey data is weakest and not acceptable as the sole basis.
For each family, the lender needs to understand how the IP produces revenue — direct licensing, embedded product revenue, retention of customer relationships. The revenue attribution must be specific and defensible — generic platform revenue is not a basis for IP collateral.
UK and EU patent court reform has produced more consistent enforcement outcomes since 2023, and lenders increasingly require explicit framework references rather than general assertions of enforceability. Patents granted in multiple jurisdictions with clear claim defensibility carry the highest collateral weighting.
In the unlikely event of default, the lender needs to understand how the IP can be monetised by a third party. For licensable IP this is straightforward — the licence can be transferred. For embedded IP, the question is harder — can a successor buyer commercialise the IP independently of the failing platform? Founders who address this question in advance carry higher collateral confidence.
A UK perovskite specialist held 8 issued patents across composition and stability chemistry, externally valued at £6m through RFR with disclosed comparable rates. The IP register documented family-level claim breadth, jurisdictional coverage across UK/EU/US/JP/KR, and a third-party licence already in place producing actual royalty income. The founder secured a £3.8m IP-backed facility from a UK clearing bank at a 63% advance rate against the externally valued amount, with a 4-year term and a margin of base + 4.5%. Without the prepared register and external valuation, the bank would not have entertained the conversation.
UK cleantech IP-backed lending facilities follow a standard structural framework in 2026.
| Structural element | Standard 2026 form |
|---|---|
| Security | First-ranking charge over the IP assets, plus debenture over the holding entity |
| Advance rate | 50-65% of externally valued fair value |
| Loan-to-value covenant | Tested annually against re-valuation |
| Re-valuation cycle | Annual independent re-valuation required |
| Interest | Cash-pay during term, no PIK component |
| Covenants | Minimum DSCR (where revenue is generated), minimum patent family count, maintenance of patent renewals |
| Default triggers | Patent revocation, loss of key family, IP transfer without consent |
| Step-in rights | Lender can take title to IP and licence to a third party in default scenario |
The standard structure favours larger, more mature cleantech businesses with consistent revenue. Smaller and earlier-stage businesses are better served by specialist IP lenders with more accommodating covenants, at higher cost of debt.
The lender wants annual re-valuation, defensible enforcement framework and clear exit mechanism. Founders who provide these elements in advance set the structure on their own terms. Those who do not get refused or get worse terms.
UK cleantech businesses raising IP-backed debt typically have other capital structures in play. Three interactions matter.
IP-backed debt is complementary to equity for cleantech founders raising growth capital. The debt is non-dilutive against the IP asset base, while equity covers operational growth and commercialisation. The two work together — investors generally prefer founders who have credit lines secured against the IP because it reduces equity capital intensity.
For cleantech businesses operating physical projects (utility-scale solar, wind, storage), the IP-backed lending sits at the platform level while project finance sits at the SPV level. The two are independent — IP-backed debt does not affect the project finance security pack, though the platform's IP can appear as tier-3 supplementary security on project debt. See Intangibles in solar project finance.
Innovate UK grants and EIS / SEIS investment can fund the IP development that underpins the future debt facility. The IP register can be built as the patent portfolio matures, and the debt becomes available once the portfolio carries enforceable patents and demonstrable monetisation pathway.
Three reasons recur in 2025-2026 declines.
No external valuation. The single most common failure. Lenders cannot recognise IP collateral that has not been independently valued by a qualified third party. Founder estimates do not count.
Single-jurisdiction patent coverage. Patents granted only in the UK without EU/US equivalents typically attract lower advance rates and may be excluded from the security pack entirely. Cleantech IP defensibility requires multi-jurisdictional coverage.
Monetisation pathway not articulated. Lenders need to understand how the IP produces revenue, today or plausibly in the near term. Pre-revenue IP without a clear monetisation pathway is rarely accepted as collateral by clearing banks (specialist lenders may take it).
Useful life not defended. Useful life claims of 15+ years on fast-moving cleantech IP without supporting analysis get rejected. Each family's useful life must reflect both legal and economic life, defensibly.
Founder-only enforcement framework. Where the patents depend on the founder for prosecution, defence and licensing, lenders heavily discount or refuse to advance. Institutional handling of IP — IP policy, defence budget, professional patent counsel relationships — is increasingly required.
A UK hydrogen electrolyser developer applied for a £5m IP-backed facility with a six-patent UK portfolio, no external valuation, and a founder-driven IP defence strategy. The clearing bank declined. Six months later, the founder returned with a refiled portfolio including US and EU equivalents, an independent IFRS-3 valuation at £8.5m, a formal IP policy, and a relationship with a major UK patent firm for defence. The facility was approved at 60% advance against the valued amount.
Three actions for UK cleantech founders considering IP-backed lending.
Build the IP register six months before the facility is needed. External valuation, comparable evidence, monetisation pathway — these elements take time to assemble. Founders who start the work in advance of the actual financing requirement have stronger conversations.
File patent equivalents in EU and US. UK-only coverage materially restricts collateral value. A six-jurisdiction filing strategy (UK, EU EPO, US, JP, KR, CN) maximises advance rate.
Engage with UKIPO IP audit programmes. UKIPO offers IP audits at concessional rates that produce defensible registers. The output is acceptable to clearing banks as part of the credit pack.
See IP lending eligibility framework, IP lending calculator and the Opagio IP Audit waitlist.
Not typically from clearing banks. Pre-revenue businesses without monetisation pathway evidence cannot meet clearing bank credit criteria, even with strong IP. Specialist IP lenders may consider pre-revenue cleantech businesses where the IP is exceptionally strong and a clear commercialisation timeline exists. Government-backed schemes can bridge some pre-revenue cases.
Independent IFRS-3-aligned IP valuation for a cleantech portfolio of 5-15 patents typically costs £15-40k from a specialist firm, with additional cost for litigation-grade defence preparation. UKIPO IP audit programmes provide partial subsidy for SMEs. Opagio Intangibles produces the register at platform-software economics; book a demo for pricing.
UK clearing bank pricing in 2026 sits at base rate + 3-6% for cleantech IP-backed facilities, depending on the strength of the IP portfolio, the cash-flow profile of the business and the structural framework of the facility. Specialist IP lenders price at base + 6-10%. Government-backed schemes can offer materially lower margins.
Not equally. Patents in clusters with disclosed comparable licence rates (battery management firmware, tracker control) are easier to value defensibly and attract higher advance rates. Patents in clusters where the licensing market is emerging (perovskite, hydrogen electrolyser) require more interpretive valuation work and may attract lower advance rates while the comparable evidence base matures.
Opagio is not a lender. Opagio Intangibles produces the IP register and IFRS-3-aligned valuation that founders take to their clearing bank or specialist IP lender. The register and valuation are designed to be acceptable to UK clearing banks under their IP-backed lending pilots. Book a demo.
Venture debt is unsecured (or lightly secured) revenue-based debt typically used by VC-backed businesses to extend equity runway. IP-backed lending is asset-secured debt that requires defensible collateral in the form of an IP register. The two can co-exist — IP-backed lending generally has lower margin and longer term than venture debt because the lender has explicit security.
The UK is materially ahead of the EU on IP-backed lending for cleantech in 2026 — clearing bank pilots are at standardised-product stage in the UK, while EU bank engagement is still early-pilot or absent. The US has a longer history of IP-backed lending but it concentrated in larger transactions; the SME cleantech segment has less infrastructure. UK cleantech founders are better served domestically for IP-backed debt in 2026.
Ivan Gowan is the Founder and CEO of Opagio. He brings 25 years of experience building and scaling technology platforms in financial services. Meet the team.
Clean energy project finance treats the panels, turbines and grid connections as the value story. The intangibles — PPAs, REC contracts, grid rights, patented technology, brand — frequently carry more enterprise value than the hardware. A practitioner guide for PE/infrastructure investors and CFOs.
Read more →
A practical framework for using intellectual property as loan collateral in the UK — which IP categories qualify, legal requirements, collateral suitability scoring, and common pitfalls.
Read more →
A comprehensive guide to using intellectual property as loan collateral. Covers IP holdco structures, patent-backed lending, valuation requirements, and practical steps for founders and PE firms seeking capital-efficient growth financing. Abstract visualization of intellectual property assets connected to financial lending structures with warm accent colours
Read more →Get the latest insights on intangible asset growth and productivity delivered to your inbox.
Book a free consultation to see how Opagio Intangibles can help your business.